In another example, low PLAC2 expression predicted poor survival in NSCLC patients, and the overexpression of PLAC2 downregulated miR-21 and upregulated PTEN, a direct target of miR-21 [50]. The gene discussed is TINCR; the disease is non-small cell lung carcinoma.